Adaptimmune Therapeutics(ADAPY)
$0.03+0.00 (+7.14%)
ADAPY
Adaptimmune Therapeutics earnings date
$0.03
At close:+0.00 (+7.14%)
Want to see ADAPY full AI Analyst Report?
Adaptimmune Therapeutics (ADAPY) Q3 2022 Earnings Report
1,249 Followers
ADAPY Q3 2022 EPS Results
- Actual EPS
- -$0.25
- Consensus EPS
- -$0.25
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$0.05
ADAPY Q3 2022 Revenue Results
- Actual Revenue
- $6.94M
- Expected Revenue
- $6.93M
- Beat/Miss
- Beat by +$14.99K
- YoY Revenue Growth
- +479.83%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/08/2022
- Time
- Before Open
- Conference Call
- Tuesday, November 8, 2022
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
ADAPY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 12, 2026 | 2026 (Q2) | ―- | -0.12 | ― | |
| May 20, 2026 | 2026 (Q1) | -0.03- | -0.03 | ― | |
| Mar 10, 2026 | 2025 (Q4) | -0.06-0.03 | -0.05 | 40.00% (+0.02) | |
| Nov 05, 2025 | 2025 (Q3) | -0.12- | -0.01 | ― | |
| Aug 13, 2025 | 2025 (Q2) | -0.04-0.02 | 0.04 | -150.00% (-0.06) | |
| May 13, 2025 | 2025 (Q1) | -0.09-0.03 | -0.03 | 0.00% (+0.00) | |
| Mar 20, 2025 | 2024 (Q4) | -0.03-0.05 | -0.04 | -25.00% (-0.01) | |
| Nov 13, 2024 | 2024 (Q3) | -0.01-0.01 | -0.03 | 66.67% (+0.02) | |
| Aug 12, 2024 | 2024 (Q2) | -0.040.04 | -0.02 | 300.00% (+0.06) | |
| May 15, 2024 | 2024 (Q1) | -0.15-0.03 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
